Shirley S Wong COSA-IPOS Joint Scientific Meeting 2012

Abstracts this author is presenting:

• A phase 1b study of trebananib (AMG 386) in combination with pegylated liposomal doxorubicin (PLD) or topotecan (T) in women with recurrent ovarian cancer — COSA Posters: Clinical Research